Table 1

Characteristics of subjects1
Placebo LC P
(n = 19) (n = 20) values2
Gender (male) 19 20 -
Age (y) 72.7 ± 10.1 (74.0) 71.9 ± 10.6 (72.0) 0.80
Systolic blood pressure (mmHg) 127.3 ± 6.0 (128.0) 128.4 ± 10.4 (130.0) 0.68
Diastolic blood pressure (mmHg) 74.5 ± 4.4 (74.0) 72.3 ± 4.7 (71.0) 0.22
Waist circumference (cm) 97.7 ± 11.4 (96.0) 91.4 ± 8.4 (91.5) 0.08
Waist hip ratio 0.9 ± 0.1 (0.9) 0.9 ± 0.1 (0.9) 0.09
Body mass index (kg/m2) 26.0 ± 2.4 (25.6) 24.8 ± 2.6 (24.6) 0.16
Creatinine (μmol/L) 106.1 ± 44.2 (97.2) 114.9 ± 26.5 (106.1) 0.33
Total cholesterol (mmol/L) 5.0 ± 1.2 (4.6) 4.9 ± 0.7 (4.9) 0.76
Triglyceride (mmol/L) 1.7 ± 0.7 (1.6) 1.4 ± 0.7 (1.1) 0.13
Low density lipoprotein-cholesterol (mmol/L) 3.0 ± 1.3 (3.0) 3.0 ± 0.7 (3.1) 0.97
High density lipoprotein-cholesterol (mmol/L) 1.2 ± 0.2 (1.2) 1.4 ± 0.4 (1.3) 0.10
Current smoker3, n (%) 3 (15.8%) 4 (20.0%) 1.00
Drink alcohol4, n (%) 3 (15.8%) 3 (15.0%) 1.00
Exercise5, n (%) 17 (89.5%) 20 (100%) 0.23

1mean ± SD (median).

2values are significantly different between the placebo and LC groups.

3current smoker: individual currently smoking one or more cigarettes per day.

4drink alcohol: individual drinking one or more drinks per day regularly.

5exercise: individual exercising at least 3 times every week.

LC, L-carnitine.

Lee et al.

Lee et al. Nutrition Journal 2014 13:79   doi:10.1186/1475-2891-13-79

Open Data